Healthcare Infection Control Practices Advisory Committee (HICPAC), 8256-8257 [2022-03038]
Download as PDF
<![CDATA[
8256
Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–03081 Filed 2–11–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Board of Scientific
Counselors, National Institute for
Occupational Safety and Health (BSC,
NIOSH)
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
BSC, NIOSH. The BSC NIOSH consists
of 15 experts in fields associated with
occupational safety and health, such as
occupational medicine, occupational
nursing, industrial hygiene,
occupational safety, engineering,
toxicology, chemistry, safety and health
education, ergonomics, epidemiology,
biostatistics, psychology, wellness,
research translation, and evaluation.
DATES: Nominations for membership on
the BSC, NIOSH must be received no
later than April 15, 2022. Packages
received after this time will not be
considered for the current membership
cycle.
ADDRESSES: All nominations should be
mailed to NIOSH Docket 278, c/o
Pauline Benjamin, Committee
Management Specialist, National
Institute for Occupational Safety and
Health, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
V–24–4, Atlanta, Georgia 30329–4027,
or emailed (recommended) to
nioshdocket@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Emily J.K. Novicki, M.A., M.P.H.,
NIOSH, CDC, 1600 Clifton Road NE, MS
V24–4, Atlanta, GA, 30329–4027,
Telephone: (404) 498–2581, or email at
ENovicki@cdc.gov.
SUPPLEMENTARY INFORMATION:
Nominations are being sought for
indviduals who have the expertise and
qualifications necessary to contribute to
the accomplishments of the Board’s
objectives. Nominees will be selected
based on expertise in the fields
associated with occupational safety and
health, such as occupational medicine,
occupational nursing, industrial
hygiene, occupational safety,
engineering, toxicology, chemistry,
jspears on DSK121TN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:54 Feb 11, 2022
Jkt 256001
safety and health education,
ergonomics, epidemiology, biostatistics,
psychology, wellness, research
translation, and evaluation. Federal
employees will not be considered for
membership. Members may be invited
to serve for up to four-year terms.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of NIOSH BSC
objectives https://www.cdc.gov/niosh/
bsc/default.html.
The U.S. Department of Health and
Human Services policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens,
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees (SGEs), requiring the filing
of financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for BSC, NIOSH membership each year
and provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in January 2023, or
as soon as the HHS selection process is
completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year. SGE nominees must be
U.S. citizens, and cannot be full-time
employees of the U.S. Government.
Candidates should submit the
following items:
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address)
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the
candidate him- or herself, or by the
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
person/organization recommending the
candidate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–03037 Filed 2–11–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This virtual meeting is open
to the public, limited only by audio and
web conference lines (300 audio and
web conference lines are available).
Registration is required. To register for
this web conference, please go to:
www.cdc.gov/hicpac. All registered
participants will receive the meeting
link and instructions shortly before the
meeting.
DATES: The meeting will be held on
March 24, 2022, from 12:00 p.m. to 2:30
p.m., EDT.
ADDRESSES: Please click the link below
to join the webinar: https://
cdc.zoomgov.com/j/1609325835?
pwd=M2Nqa0VMSExYS1RCUj
RKeTVvTzFnZz09.
Meeting ID: 160 932 5835.
Passcode: b#B0i6q.
Dial-in Lines:
+1–669–254–5252 (San Jose)
+1–646–828–7666 (New York)
Meeting ID: 160 932 5835.
Phone Passcode: 45841052.
FOR FURTHER INFORMATION CONTACT:
Sydnee Byrd, M.P.A., HICPAC, Division
of Healthcare Quality Promotion,
SUMMARY:
E:\FR\FM\14FEN1.SGM
14FEN1
jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices
National Center for Emerging and
Zoonotic Infectious Diseases, CDC, 1600
Clifton Road NE, Mailstop H16–3,
Atlanta, Georgia 30329–4027,
Telephone: (404) 718–8039; Email:
HICPAC@cdc.gov.
Prevention and the Agency for Toxic
Substances and Disease Registry.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2022–03038 Filed 2–11–22; 8:45 am]
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, the Secretary, Health
and Human Services regarding (1) the
practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters to be Considered: The agenda
will include the following updates: The
Healthcare Personnel Guideline
Workgroup; the Isolation Precautions
Guideline Workgroup; and the Neonatal
Intensive Care Unit Workgroup. Agenda
items are subject to change as priorities
dictate.
Procedures for Public Comment: Time
will be available for public comment.
Members of the public who wish to
provide public comments should plan
to attend the public comment session at
the start time listed. Please note that the
public comment period may end before
the time indicated, following the last
call for comments.
Procedures for Written Comment: The
public may submit written comments in
advance of the meeting. Comments
should be submitted in writing by email
to the contact person listed above. The
deadline for receipt of written public
comment is March 18, 2022. All
requests must contain the name,
address, and organizational affiliation of
the speaker, as well as the topic being
addressed. Written comments should
not exceed one single-spaced typed page
in length. Written comments received in
advance of the meeting will be included
in the official record of the meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
BILLING CODE 4163–18–P
VerDate Sep<11>2014
17:54 Feb 11, 2022
Jkt 256001
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–0728; Docket No. CDC–2022–
0020]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled National Notifiable Diseases
Surveillance System (NNDSS). The
purpose of this data collection is to
provide the official source of statistics
in the United States for nationally
notifiable conditions.
DATES: CDC must receive written
comments on or before April 15, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0020 by either of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
SUMMARY:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
8257
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
National Notifiable Diseases
Surveillance System (NNDSS) (OMB
Control No. 0920–0728, Exp. 3/31/
2024)—Revision—Center for
Surveillance, Epidemiology and
Laboratory Services (CSELS), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Public Health Services Act (42
U.S.C. 241) authorizes CDC to
disseminate nationally notifiable
condition information. The National
E:\FR\FM\14FEN1.SGM
14FEN1
]]>Agencies
[Federal Register Volume 87, Number 30 (Monday, February 14, 2022)]
[Notices]
[Pages 8256-8257]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03038]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Healthcare Infection Control
Practices Advisory Committee (HICPAC). This virtual meeting is open to
the public, limited only by audio and web conference lines (300 audio
and web conference lines are available). Registration is required. To
register for this web conference, please go to: www.cdc.gov/hicpac. All
registered participants will receive the meeting link and instructions
shortly before the meeting.
DATES: The meeting will be held on March 24, 2022, from 12:00 p.m. to
2:30 p.m., EDT.
ADDRESSES: Please click the link below to join the webinar: https://cdc.zoomgov.com/j/1609325835?pwd=M2Nqa0VMSExYS1RCUjRKeTVvTzFnZz09.
Meeting ID: 160 932 5835.
Passcode: b#B0i6q.
Dial-in Lines:
+1-669-254-5252 (San Jose)
+1-646-828-7666 (New York)
Meeting ID: 160 932 5835.
Phone Passcode: 45841052.
FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., HICPAC, Division
of Healthcare Quality Promotion,
[[Page 8257]]
National Center for Emerging and Zoonotic Infectious Diseases, CDC,
1600 Clifton Road NE, Mailstop H16-3, Atlanta, Georgia 30329-4027,
Telephone: (404) 718-8039; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion
(DHQP), the Director, National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health
and Human Services regarding (1) the practice of healthcare infection
prevention and control; (2) strategies for surveillance, prevention,
and control of infections, antimicrobial resistance, and related events
in settings where healthcare is provided; and (3) periodic updating of
CDC guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters to be Considered: The agenda will include the following
updates: The Healthcare Personnel Guideline Workgroup; the Isolation
Precautions Guideline Workgroup; and the Neonatal Intensive Care Unit
Workgroup. Agenda items are subject to change as priorities dictate.
Procedures for Public Comment: Time will be available for public
comment. Members of the public who wish to provide public comments
should plan to attend the public comment session at the start time
listed. Please note that the public comment period may end before the
time indicated, following the last call for comments.
Procedures for Written Comment: The public may submit written
comments in advance of the meeting. Comments should be submitted in
writing by email to the contact person listed above. The deadline for
receipt of written public comment is March 18, 2022. All requests must
contain the name, address, and organizational affiliation of the
speaker, as well as the topic being addressed. Written comments should
not exceed one single-spaced typed page in length. Written comments
received in advance of the meeting will be included in the official
record of the meeting.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-03038 Filed 2-11-22; 8:45 am]
BILLING CODE 4163-18-P
